Comparison of E-cadherin and CD56 Expression in Papillary Thyroid Carcinoma and Non-Neoplastic Thyroid Lesions

被引:0
|
作者
Thomas, Sumi [1 ]
Surendran, Divya [1 ]
Augustine, Joy [1 ]
机构
[1] Amala Inst Med Sci, Dept Pathol, Trichur 680555, Kerala, India
关键词
Immunohistochemistry; Neural cell adhesion molecule; Transmembrane glycoprotein; CLINICAL-SIGNIFICANCE; DIAGNOSTIC-VALUE; CANCER;
D O I
10.7860/JCDR/2020/43912.13809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Papillary Thyroid Carcinomas (PTC) are the most common among thyroid malignancies. The incidence of this tumour is rapidly increasing around the world. Kerala has the highest incidence of this tumour in India. Abnormalities in adhesion molecules, E-cadherin and CD56 have recently been implicated in thyroid tumourigenesis. Sometimes the diagnosis of PTC is difficult, as there are a good number of histological variants and some may be encapsulated. In such situations, evaluation of the expression of adhesion molecules like E-cadherin and CD56 are useful in accurate diagnosis. Aim: To study the Immunohistochemical Expression of E-cadherin and CD56 in PTC, its adjacent normal thyroid tissue and other non-neoplastic thyroid lesions. Materials and Methods: This was a descriptive study conducted at Amala Institute of Medical Sciences, Thrissur from January 2018 to June 2019. Seventy six thyroidectomy specimens (38 each of PTC and Non-neoplastic lesions) were studied after satisfying the inclusion and exclusion criteria. Microscopic examination of the Haematoxylin and Eosin stained sections were done for selecting the representative tissue block to immunostain for E-cadherin and CD56. Statistical analysis was performed using Chi-square test and Fisher's-exact tests. P-value of <0.05 was considered as significant. Results: E-cadherin expression was negative in 37 cases of PTC. Only two non-neoplastic lesions were negative for E-cadherin( p-value of 0.021). No significant correlation was observed between E-cadherin expression and poor prognostic factors (tumour diameter, multifocality, extrathyroidal extension and lymph node metastasis). All PTC cases showed negative CD56 expression. A total of 34 out of 38 Non-neoplastic cases showed positive CD56 staining (significant p value=0.011). In non-neoplastic lesions, E-cadherin and CD56 were preserved. CD56 showed highest specificity (100%). Conclusion: PTC was characterised by decreased or absent expression of E-cadherin as compared to the adjacent thyroid tissue. CD56 expression was uniformly negative in all the PTC cases. CD56 marker had highest specificity (100%). In follicular patterned thyroid lesions, CD56 as a single marker may be useful for identifying PTC from other thyroid lesions in daily practice. To conclude, CD56 negativity and E-cadherin loss can assist in decision making of difficult cases.
引用
收藏
页码:EC01 / EC05
页数:5
相关论文
共 50 条
  • [1] Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin
    Ceyran, Ayse Bahar
    Senol, Serkan
    Simsek, Bengu Cobanoglu
    Sagiroglu, Julide
    Aydin, Abdullah
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (04): : 3670 - 3680
  • [2] Expression of Immunohistochemical Markers in Papillary Carcinoma Thyroid and Non-Neoplastic Lesions of Thyroid
    Priyadarshini, Gayathri R. S.
    Karkuzhali, Ponnuswamy
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2021, 9 (06): : 439 - 449
  • [3] Expression of E-cadherin in papillary thyroid carcinoma
    Bich, T.
    Nerovnya, A.
    Cherstvoy, E.
    VIRCHOWS ARCHIV, 2009, 455 : 381 - 381
  • [4] Expression of Immunohistochemical Markers (CD56 and P63) in Various Non-Neoplastic and Neoplastic Lesions of Thyroid Gland
    Sasi, Resmi P.
    Sushma
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2020, 14 (02)
  • [5] The absence of CD56 expression can differentiate papillary thyroid carcinoma from other thyroid lesions
    Golu, Ioana
    Vlad, Mihaela Maria
    Dema, Alis
    Moleriu, Lavinia Cristina
    Tudor, Anca
    Iacob, Mihaela
    Popa, Oana
    Cornianu, Marioara
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2017, 60 (02) : 161 - 166
  • [6] Prognostic significance of e-cadherin in papillary thyroid carcinoma
    Walgenbach, S
    Sternheim, E
    Bittinger, F
    Gorges, R
    Andreas, JA
    Junginger, T
    CHIRURG, 1998, 69 (02): : 186 - 190
  • [7] Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid
    El Demellawy, Dina
    Nasr, Ahmed Lotfy
    Babay, Slim
    Alowami, Salem
    PATHOLOGY RESEARCH AND PRACTICE, 2009, 205 (05) : 303 - 309
  • [8] CD56 expression in benign and malignant thyroid lesions
    Muthusamy, Santhia
    Azhar Shah, Shamsul
    Abdullah Suhaimi, Shahrun Niza
    Kassim, Norina
    Mahasin, Mazne
    Mohd Saleh, Muhammad Fakhri
    Md Isa, Nurismah
    MALAYSIAN JOURNAL OF PATHOLOGY, 2018, 40 (02) : 111 - 119
  • [9] CD56, HBME-1 and cytokeratin 19 expressions in papillary thyroid carcinoma and nodular thyroid lesions
    Erdogan-Durmus, Senay
    Ozcan, Deniz
    Yarikkaya, Enver
    Kurt, Ali
    Arslan, Aynur
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2016, 21
  • [10] E-cadherin expression in follicular carcinoma of the thyroid
    Kato, N
    Tsuchiya, T
    Tamura, G
    Motoyama, T
    PATHOLOGY INTERNATIONAL, 2002, 52 (01) : 13 - 18